T-Cells: Unraveling Their Complex Role in Autoimmunity
Written on
T-cells, often hailed as the defenders against cancer, can paradoxically pose a significant threat to the brain. My grandfather's battle with bladder cancer began when I was just a child; he endured extensive chemotherapy and is still on the path to recovery. His doctors have suggested he explore alternative treatments, including those that utilize T-cells.
T-cells play a crucial role in eliminating cancer cells in our bodies. Immunotherapy techniques, such as CAR-T cell therapy, involve customizing T-cells derived from a patient’s blood to enhance their ability to attack cancer.
Cancer arises when uncontrolled cell division leads to rapid proliferation of abnormal cells. Conversely, when T-cells misbehave, they can trigger autoimmune diseases such as HIV, rheumatoid arthritis, and multiple sclerosis. Before delving into the darker implications of T-cells, it’s essential to understand how the immune system, particularly the lymphatic system, is designed to function.
The Lymphatic System
The significance of face masks is widely recognized. Pathogens like viruses and bacteria can enter our bodies through the mouth or nose via inhaled air particles. Once inside, they can spread throughout the body, aided by both the circulatory and lymphatic systems.
The lymphatic system serves as a secondary transport mechanism distinct from blood circulation, responsible for producing and transporting B and T-cells. It consists of numerous lymph vessels and nodes. Unlike the circulatory system, where blood is propelled by the heart, lymph moves through the contraction of surrounding muscles.
To illustrate this, consider a garden hose: if you step on it, the water inside is forced to flow in a specific direction. The water represents lymph, which is vital for the body’s immune response.
The Immune System
For a foreign entity to successfully invade, it must evade the immune system, which is organized into three primary lines of defense.
#### The First Line of Defense
The skin and mucous membranes constitute the first line of defense, where immune responses are generally non-specific and do not target specific pathogens.
#### The Second Line of Defense
The second line includes NK (natural killer) cells and antimicrobial proteins. NK cells eliminate cells infected by viruses or cancer, while antimicrobial proteins disrupt the membranes of bacteria and fungi. Inflammation occurs at this stage, causing infected areas to feel hot as the body raises temperatures to deactivate harmful enzymes.
#### The Third Line of Defense
The third line comprises B-cells, T-cells, and antibodies. Antibodies are proteins that bind to specific antigens (unique proteins on pathogens). They function like handcuffs, neutralizing antigens to prevent them from triggering further immune responses. Once attached, antibodies are engulfed by macrophages for recycling.
B-cells are tasked with identifying pathogens and generating a humoral response, producing antibodies for any antigens they encounter in the bloodstream or lymph. However, if a pathogen overwhelms B-cells, T-cells step in.
Helper T-cells (Th-cells) mobilize other T-cells to destroy invaders and prompt B-cells to create antibodies, acting as the commanders of the immune response. Cytotoxic T-cells function as the soldiers, attacking infected cells. Th-cells identify infected cells through major histocompatibility proteins (MHC) that display antigens, triggering a cascade of immune signals known as cytokines.
But what happens when Th-cells and cytotoxic T-cells fail to perform their roles effectively?
The Dark Side: Multiple Sclerosis
Autoimmune diseases occur when the body mistakenly targets its healthy cells. Research indicates that women are diagnosed with autoimmune conditions at nearly twice the rate of men—6.4% versus 2.7%. These diseases often manifest during a woman's reproductive years (ages 15 to 44).
The exact causes of autoimmune diseases remain largely a mystery. One prevalent theory, the hygiene hypothesis, suggests that reduced exposure to germs in modern times—thanks to vaccines and antibiotics—leaves immune systems less equipped to handle various pathogens. Another theory links autoimmune conditions to a Western diet high in sugar and fats, which can trigger inflammation, a precursor to many autoimmune diseases.
Environmental factors, such as carcinogens and mutagens like tobacco and UV radiation, may also play a role. Additionally, certain autoimmune diseases, including multiple sclerosis (MS) and lupus, can be hereditary, with familial patterns of susceptibility.
My current focus is on multiple sclerosis (MS) and its connection to T-cells crossing the blood-brain barrier. MS damages the myelin sheath—the protective layer surrounding nerve cells in the central nervous system (CNS)—leading to delayed transmission of signals between the brain, spinal cord, and body.
This damage can cause symptoms like numbness, weakness, and balance issues, with progression rates varying by individual. Research from Dr. Marvin Goldenberg in 2012 indicated that approximately half of MS patients require assistance with mobility within 15 years of diagnosis.
A 2020 study led by neuro-immunologist Norio Chihara found that CD4+ T-cells (including Th1 and Th17 cells) contribute to inflammation in the early stages of MS.
These T-cells disrupt the CNS by releasing interleukins, a type of cytokine that breaches the blood-brain barrier, which is designed to protect the CNS from toxins and harmful immune cells. However, T-cells are not the sole contributors to MS pathology.
In the initial relapsing-remitting phase of MS, various immune cells, including CD4+ T-cells, CD8+ T-cells, B-cells, and macrophages, infiltrate the blood-brain barrier, damaging microglia and myelin sheaths.
Understanding the role of the blood-brain barrier and its cellular components requires further exploration.
T-cell subtypes can either be nonpathogenic or pathogenic. For instance, nonpathogenic Th17 cells produce IL-9 and IL-10, while pathogenic variants release IL-17 and other inflammatory interleukins, with IL-12 being particularly hazardous in MS cases. IL-12 activates platelets, leading to an exacerbated inflammatory response against myelin.
Typically, T-cells target abnormal cells by recognizing antigens. However, in the context of MS, this targeting mechanism fails. One theory posits that surface proteins CD80 and CD86 on T-helper cells may be linked to brain inflammatory lesions, including MS plaques.
Before a definitive cure for autoimmune diseases like MS can be found, extensive research is necessary to unravel the complexities of the immune system. Immunologists must particularly investigate what I refer to as the dark side of T-cells.
Thank you for reading this article. It’s fascinating to consider that T-cells, our body's most formidable defenders, may also harbor a sinister side.
Feel free to connect with me on LinkedIn or reach out at [email protected] for inquiries or discussions.
Follow Bioeconomy.XYZ to discover how biotechnology is influencing our world.
Bioeconomy.XYZ is dedicated to making biotechnology and its various fields accessible to everyone.